(Q36137624)

English

Consolidation therapy with weekly paclitaxel infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: an extended follow-up

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

Consolidation therapy with weekly paclitaxel infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: an extended follow-up (English)

1 reference

Europe PubMed Central

12 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Elizabeth N Skinner

1

1 reference

Europe PubMed Central

12 August 2017

David M Boruta

2

1 reference

Europe PubMed Central

12 August 2017

Paola A Gehrig

3

1 reference

Europe PubMed Central

12 August 2017

John F Boggess

4

1 reference

Europe PubMed Central

12 August 2017

Wesley C Fowler

5

1 reference

Europe PubMed Central

12 August 2017

Linda Van Le

6

1 reference

Europe PubMed Central

12 August 2017

language of work or name

0 references

publication date

1 July 2005

1 reference

Europe PubMed Central

12 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

12 August 2017

98

1 reference

Europe PubMed Central

12 August 2017

1

1 reference

Europe PubMed Central

12 August 2017

59-62

1 reference

Europe PubMed Central

12 August 2017

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatme

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Consolidation radiation therapy following cytoreductive surgery, chemotherapy and second-look laparotomy for epithelial ovarian carcinoma: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group tria

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.004

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.04.004

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36137624&oldid=1618721922"